Method for Continuous Infusion into the Portal Vein of Mice

Laboratory Animal Science

Volumn 48, Issue 4, 1998, Pages 379-383

  Patijn, Gijsbert A ^a,b   Terpstra, Onno T ^b   Kay, Mark A ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENE EXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; HOST CELL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MOUSE; NONHUMAN; PORTAL VEIN BLOOD FLOW;

ANIMALS; BODY WEIGHT; DNA, RECOMBINANT; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INFUSIONS, INTRAVENOUS; KIDNEY; LIVER; MICE; MICE, INBRED C57BL; ORGAN SIZE; PORTAL VEIN; RETROVIRIDAE;

EID: 0031690180     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Patijn, G., A. Lieber, D. B. Schowaiter, et al. Hepatocyte growth factor (HGF) induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology, in press.
2. Patijn, G., A. Lieber, L. Meuse, et al. High-efficiency retroviral-mediated gene transfer into the livers of mice. Hum. Gene Ther., in press.
3. Ferry, N., O. Duplessis, D. Houssin, et al. 1991. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88:8377-8381.
4. Kaleko, M., J. V. Garcia, and A, D. Miller. 1991. Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum. Gene Ther. 2:27-32.
5. Kay, M. A., Q. Li, T. J. Liu, et al. 1992. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3:641-647.
6. Kay, M. A., S. Rothenberg, C. N. Landen, et al. 1993. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262:117-119.
7. Kolodka, T. M., M. Finegold, M. A. Kay, et al. 1993. Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo (published erratum appears in Somat Cell Mol. Genet. 1994, 20:251). Somat Cell Mol. Genet. 12:491-497.
8. Rettinger, S. D., S. C. Kennedy, X. Wu, et al. 1994. Liverdirected gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91:1460-1464.
9. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
10. Andreadis, S. T., D. Brott, A. O. Fuller, et al. 1997. Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 71:7541-7548.
11. Rozga, J., A. D. Moscioni, D. Neuzil, et al. 1992. A model for directed foreign gene delivery to rat liver cells in vivo. J. Surg. Res. 52:209-213.
12. Lieber, A., M. J. T. F. D. Vrancken Peeters, L. Meuse, et al. 1995. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:6210-6214.
13. Bosch, A., P. B. McCray, S. M. W. Chang, et al. 1996. Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J. Clin. Invest. 98:2683-2687.
14. Bewles, N. E., R. C. Eisensmith, R. Mohuiddin, et al. 1996. A simple and efficient method for the concentration and purification of recombinant retroviruses for increased hepatocyte transduction in vivo. Hum. Gene Ther. 7:1735-1742.
15. Kitten, O., F. L. Cosset, and N. Ferry. 1997. Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo. Hum. Gene Ther. 8:1491-1494.
16. Cosset, F., Y. Takeuchi, J. Battini, et al. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
17. Branchereau, S., D. Calise, and N. Ferry. 1994. Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo. Hum. Gene Ther. 5:803-808.
18. Podevin, G., N. Ferry, D. Calise, et al. 1996. In vivo retroviral-mediated transfer of a marker gene in ornithine transcarbamylase-deficient Spflash) mice. J. Pediatr. Surg. 31:1516-1519.
19. Vrancken-Peeters, M. J. T. F. D., A. Lieber, J. Perkins, et al. 1996. A method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. Biotechniques 20:278-285.
20. Hodge, D., and M. Shalev. 1992. Dual cannulation: a method for continuous intravenous infusion and repeated blood sampling in unrestrained mice. Lab. Anim. Sci. 42:320-322.
21. Barr, J. E., D. B. Holmes, L. J. Ryan, et al. 1979. Techniques for the chronic cannulation of the jugular vein in mice. Pharmacol. Biochem. Behav. 11:115-118.
22. Sitren, H. S., P. A. Heller, L. B. Bailey, et al. 1983. Total parenteral nutrition in the mouse: development of a technique. J. Parent. Ent. Nutr. 7:582-586.
23. Coquelin, A., and F. H. Bronson. 1979. Release of luteinizing hormone in male mice during exposure to females: habituation of the response. Science 206:1099-1101.
24. Bartkowski, R., M. R. Berger, J. L. A. Aguiar, et al. 1986. Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2′-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. J. Cancer Res. Oncol.111:42-46.
25. Archer, S. G., and B. N. Gray. 1990. Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases. Am. J. Surg. 159:325-329.
26. Rafique, M., W. Adachi, and E. Shiohara. 1995. Establishment of an experimental model for continuous intraportal infusion of chemo/immunotherapeutic agents in the rat. Anticancer Res. 15:1869-1872.
27. Porteous, D. J., and J. R. Dorin. 1993. How relevant are mouse models for human gene therapy? Trends Biotechnol. 11:173-181.
28. Johnson-Delaney, C. A. 1996. Small rodents - mice, p. 21-37. In C. A. Johnson-Delaney and L. R. Harrison (ed.), Exotic companion medicine handbook. Wingers Publishing, Inc., Lake Worth, Fla.
29. Piccone, B. A., H. H. LeVeen, P. Glass, et al. 1980. Prehepatic hyperalimentation. Surgery 87:263-270.
30. Lui, K. X., Y. Kato, M. Narukawa, et al. 1992. Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am. J. Physiol. 263:G642-G649.
31. Zioncheck, T. F., L. Richardson, G. G. DeGuzman, et al. 1994. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 134:1879-1887.